In contrast, IL-17 deficiency mitigates arthritis development, as seen in mice that lack IL-17A (35, 36) or those treated with anti-IL-17-blocking antibodies (36, 37); IL-17 overexpression exacerbates disease progression and induces a chronic, erosive form of the disease (38). This evidence concerns the gene IL17A and Arthritis.